Effects of the non-steroidal anti-inflammatory drug celecoxib on cholesterol containing distearoyl phosphatidylcholine membranes

被引:5
|
作者
Sade, Asli [1 ]
Banerjee, Sreeparna [1 ]
Severcan, Feride [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey
来源
SPECTROSCOPY-BIOMEDICAL APPLICATIONS | 2011年 / 25卷 / 3-4期
关键词
Celecoxib; cholesterol; DSPC; FTIR; MLV; LIPID ORGANIZATION; MODEL MEMBRANES; VITAMIN D-2; FLUIDITY; SPECTROSCOPY; INHIBITORS;
D O I
10.1155/2011/813853
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The effects of different concentrations of celecoxib on the acyl chain order, dynamics and the hydration status of the head group and interfacial region of model membranes containing DSPC and cholesterol were investigated in detail using Fourier transform infrared spectroscopy. Our results reveal that regardless of the presence of cholesterol, celecoxib is able to alter the physical properties of membranes. It exerts opposing effects on membrane order at high and low concentrations and decreases membrane fluidity in the presence of cholesterol. An evidence of phase separation has also been observed. The decrease in membrane fluidity supports the hypothesis that celecoxib may induce changes in the activity of membrane bound enzymes through modulating physical properties of the membrane thereby contributing to its anticancer activity. A possible change in the location of celecoxib in DSPC membranes when cholesterol is present has also been proposed. These results clarify, to a certain extent, the molecular interactions of celecoxib with membrane systems and may additionally contribute to a better understanding of COX-2 independent mechanisms of celecoxib action.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 50 条
  • [41] Review: Cardiovascular complications of non-steroidal anti-inflammatory drugs
    Fosslien, E
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (04) : 347 - 385
  • [42] Choosing and using non-steroidal anti-inflammatory drugs in haemophilia
    Arachchillage, D. R. J.
    Makris, M.
    HAEMOPHILIA, 2016, 22 (02) : 179 - 187
  • [43] Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs
    Anwar, Asif
    Anwar, Imran John
    Delafontaine, Patrice
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (08) : 726 - 735
  • [44] Safety of Celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs
    Liccardi, G
    Cazzola, M
    De Giglio, C
    Manfredi, D
    Piscitelli, E
    D'Amato, M
    D'Amato, G
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2005, 15 (04) : 249 - 253
  • [45] Non-steroidal anti-inflammatory drugs and venous thromboembolism in women
    Bergendal, Annica
    Adami, Johanna
    Bahmanyar, Shahram
    Hedenmalm, Karin
    Larfars, Gerd
    Persson, Ingemar
    Sundstrom, Anders
    Kieler, Helle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (06) : 658 - 666
  • [46] Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk
    Shadman, Mazyar
    Newcomb, Polly A.
    Hampton, John M.
    Wernli, Karen
    Trentham-Dietz, Amy
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (19) : 2336 - 2339
  • [47] A non-steroidal anti-inflammatory drug (ketoprofen) does not delay β-TCP bone graft healing
    Nyangoga, Herve
    Aguado, Eric
    Goyenvalle, Eric
    Basle, Michel Felix
    Chappard, Daniel
    ACTA BIOMATERIALIA, 2010, 6 (08) : 3310 - 3317
  • [48] Effect of non-steroidal anti-inflammatory drug etoricoxib on the hematological parameters and enzymes of colon and kidney
    Behal, N.
    Kanwar, S. Singh
    Sharma, P.
    Sanyal, S. N.
    NUTRICION HOSPITALARIA, 2009, 24 (03) : 326 - 332
  • [49] Unmet Needs in Non-steroidal Anti-inflammatory Drug-induced Upper Gastrointestinal Diseases
    James M. Scheiman
    Drugs, 2006, 66 (Suppl 1) : 15 - 21
  • [50] Indomethacin, a Non-steroidal Anti-inflammatory Drug, Induces Skin Dryness via PPARγ in Mice
    Maruyama, Kiyoko
    Goto, Kenji
    Hiramoto, Keiichi
    Tanaka, Shota
    Ooi, Kazuya
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (01) : 77 - 85